RE:RE:Bringing it to an End!
Full of sh....it as usual , Bellus Health was listed on nasdaq and on the tsx and that did not prevent GSK to offer $2B for Bellus. A nasdaq listing makes it easier for new equities issues. Companies are rewarded when they create value for shareholders no matter what market they're listed to.
When you sit on your steak thinking a US firm or a big player will create for you the best conditions you could have never imagine then ......................
As i already mentionned : ASK YOURSELF IF THEY NEVER INTENDED TO CONDUCT ANY CLINICAL TRIAL. After all thoses years don't you think it's time.